Literature DB >> 23464817

Invasive pneumococcal disease in patients with an underlying pulmonary disorder.

M Inghammar1, G Engström, G Kahlmeter, B Ljungberg, C-G Löfdahl, A Egesten.   

Abstract

Chronic pulmonary disease is a recognized risk factor for invasive pneumococcal disease (IPD). However, previous studies have often not been large enough to allow detailed analyses of less prevalent pulmonary diseases, and findings regarding case fatality have been inconsistent. We examined the associations between an underlying pulmonary disease and IPD, and the impact of these diseases on the case fatality rate. Patients with IPD ≥18 years of age, between 1990 and 2008, were identified in microbiological databases. The associations between IPD and the pulmonary diseases were assessed using conditional logistic regression, comparing IPD cases to ten control subjects per case, randomly selected from the general population (matched for gender, year of birth and county of residence). Adjustments were made for other co-morbidities, level of education and socio-economic status, 4085 cases of IPD and 40 353 controls were identified. A more than four-fold increased risk of IPD was seen in chronic obstructive pulmonary disease, a doubled risk in asthma and a five-fold increased risk in subjects with pulmonary fibrosis. In univariate analysis, sarcoidosis and bronchiectasis were associated with a two-fold to seven-fold increase in the risk of IPD, but there was no statistical support for the associations when adjustments for confounders were made. No increased risk was seen in subjects with a history of pneumoconiosis or allergic alveolitis. The mortality following IPD was not increased in patients with chronic obstructive pulmonary disease, asthma, pulmonary fibrosis or bronchiectasis. Several chronic pulmonary diseases increase the risk of IPD but mortality following IPD seems not to be affected.
© 2013 The Authors Clinical Microbiology and Infection © 2013 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  Asthma; chronic obstructive pulmonary disease; epidemiology; pneumococcal infections; pulmonary fibrosis; sarcoidosis

Mesh:

Year:  2013        PMID: 23464817     DOI: 10.1111/1469-0691.12182

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  14 in total

Review 1.  [Vaccination in advanced age].

Authors:  H J Heppner; A Leischker; P Wutzler; A Kwetkat
Journal:  Internist (Berl)       Date:  2018-02       Impact factor: 0.743

2.  Allergic Lung Inflammation Reduces Tissue Invasion and Enhances Survival from Pulmonary Pneumococcal Infection in Mice, Which Correlates with Increased Expression of Transforming Growth Factor β1 and SiglecF(low) Alveolar Macrophages.

Authors:  Alan M Sanfilippo; Yoichi Furuya; Sean Roberts; Sharon L Salmon; Dennis W Metzger
Journal:  Infect Immun       Date:  2015-05-11       Impact factor: 3.441

Review 3.  Pneumococcal Disease in the Era of Pneumococcal Conjugate Vaccine.

Authors:  Inci Yildirim; Kimberly M Shea; Stephen I Pelton
Journal:  Infect Dis Clin North Am       Date:  2015-12       Impact factor: 5.982

4.  Influence of HLA-DR polymorphism and allergic sensitization on humoral immune responses to intact pneumococcus in a transgenic mouse model.

Authors:  Y H Sheen; G Rajagopalan; C M Snapper; H Kita; C-I Wi; P J Umaretiya; Y J Juhn
Journal:  HLA       Date:  2016-08-10       Impact factor: 4.513

Review 5.  Integrative Physiology of Pneumonia.

Authors:  Lee J Quinton; Allan J Walkey; Joseph P Mizgerd
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

6.  Pneumococcal Vaccination Among Adults With Work-related Asthma.

Authors:  Katelynn E Dodd; Jacek M Mazurek
Journal:  Am J Prev Med       Date:  2017-09-27       Impact factor: 5.043

7.  Inhaled corticosteroid suppression of cathelicidin drives dysbiosis and bacterial infection in chronic obstructive pulmonary disease.

Authors:  Aran Singanayagam; Nicholas Glanville; Leah Cuthbertson; Nathan W Bartlett; Lydia J Finney; Elena Turek; Eteri Bakhsoliani; Maria Adelaide Calderazzo; Maria-Belen Trujillo-Torralbo; Joseph Footitt; Phillip L James; Peter Fenwick; Samuel V Kemp; Thomas B Clarke; Jadwiga A Wedzicha; Michael R Edwards; Miriam Moffatt; William O Cookson; Patrick Mallia; Sebastian L Johnston
Journal:  Sci Transl Med       Date:  2019-08-28       Impact factor: 17.956

8.  Coeliac disease and invasive pneumococcal disease: a population-based cohort study.

Authors:  A Röckert Tjernberg; J Bonnedahl; M Inghammar; A Egesten; G Kahlmeter; P Nauclér; B Henriques-Normark; J F Ludvigsson
Journal:  Epidemiol Infect       Date:  2017-01-23       Impact factor: 4.434

Review 9.  Lifestyle risk factors for invasive pneumococcal disease: a systematic review.

Authors:  Helen C Cruickshank; Johanna M Jefferies; Stuart C Clarke
Journal:  BMJ Open       Date:  2014-06-20       Impact factor: 2.692

Review 10.  Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease.

Authors:  Antoni Torres; Francesco Blasi; Nathalie Dartois; Murat Akova
Journal:  Thorax       Date:  2015-07-28       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.